EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vitamin D Status Determines the Effect of Cabergoline on Sexual Function and Depressive Symptoms in Hyperprolactinemic Women

Robert Krysiak iD, Karolina Kowalcze iD, Johannes Ott iD, Andrea Deledda iD, Bogusław Okopień iD

Nutrients · 2025

DOI: 10.3390/nu17111813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Robert Krysiak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland. Hauptthemen laut MEDLINE: Cabergoline, Depression, Vitamin D, Hyperprolactinemia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia in Katowice.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Although untreated prolactin excess is often associated with female sexual dysfunction, sexual functioning improves after chronic administration of dopamine agonists, including cabergoline. Extra-sexual benefits of cabergoline therapy were found to be less pronounced in young hyperprolactinemic women in the case of coexistent hypovitaminosis D. Thus, the present study was aimed at investigating whether vitamin D status also determines cabergoline action on sexual function and depressive symptoms in reproductive-age women.

Methods

This prospective cohort study included 75 young women with prolactin excess, who, depending on vitamin D status, were assigned to one of three groups. Females with vitamin D deficiency (group A), vitamin D-insufficient women (group B) and vitamin D-sufficient women (group C) were matched for age, body mass index, blood pressure and prolactin levels. For the following six months, they received cabergoline. Before and after cabergoline treatment, all participants completed questionnaires evaluating female sexual functioning (FSFI) and depressive symptoms (BMI-II). The remaining outcomes of interest included plasma levels of 25-hydroxyvitamin D, prolactin and sex hormones.

Results

Before treatment, there were no differences between the study groups in sexual functioning and mood. The study groups differed in post-treatment levels of 25-hydroxyvitamin D, prolactin, testosterone and estradiol. Although cabergoline reduced the total FSFI score and improved functioning in all domains of the FSFI questionnaire, this effect was strongest in group C and weakest in group A. Statistically significant changes in the BDI-II score were observed only in group C. The increase in the total FSFI score and domain scores correlated with the decrease in prolactin levels, 25-hydroxyvitamin D levels, the increase in testosterone and estradiol concentrations, and the reduction in the BDI-II score.

Conclusions

Low vitamin D status attenuates the beneficial effects of cabergoline on sexual function and depressive symptoms in reproductive-age women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CabergolineDepressionVitamin DHyperprolactinemiaVitamin D DeficiencySexual Dysfunction, PhysiologicalDopamine AgonistsHumansFemaleAdultProspective StudiesYoung AdultProlactin

Stichwörter der Autor:innen

moodprolactin excessreproductive axissexual dysfunctionvitamin D homeostasiswomen’s health

Substanzen

CabergolineVitamin DDopamine Agonists25-hydroxyvitamin DProlactin

Autor:innen und Institutionen

  • Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland.
  • Department of Pediatrics in Bytom, Faculty of Health Sciences in Katowice, Medical University of Silesia, Stefana Batorego 15, 41-902 Bytom, Poland.
  • Department of Pathophysiology, Faculty of Medicine, Academy of Silesia, Rolna 43, 40-555 Katowice, Poland.
  • Clinical Division of Gynecologic Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, 1090 Vienna, Austria.
  • Endocrinology and Obesity Unit, Department of Medical Sciences and Public Health, University of Cagliari, 09124 Cagliari, Italy.

ORCID-Profile: Robert Krysiak, Karolina Kowalcze, Johannes Ott, Andrea Deledda, Bogusław Okopień

Förderung

  • Medical University of Silesia in Katowice

Zitieren

APA

Krysiak, R., Kowalcze, K., Ott, J., Deledda, A., & Okopień, B. (2025). Vitamin D Status Determines the Effect of Cabergoline on Sexual Function and Depressive Symptoms in Hyperprolactinemic Women. Nutrients. https://doi.org/10.3390/nu17111813

Vancouver

Krysiak R, Kowalcze K, Ott J, Deledda A, Okopień B. Vitamin D Status Determines the Effect of Cabergoline on Sexual Function and Depressive Symptoms in Hyperprolactinemic Women. Nutrients. 2025. doi:10.3390/nu17111813

BibTeX
@article{Krysiak2025,
  author = {Krysiak, Robert and Kowalcze, Karolina and Ott, Johannes and Deledda, Andrea and Okopień, Bogusław},
  title = {Vitamin D Status Determines the Effect of Cabergoline on Sexual Function and Depressive Symptoms in Hyperprolactinemic Women},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17111813}
}
Kostenlos starten →